Natural History Study of Patients With Limb-Girdle Muscular Dystrophy 2I

NCT03842878 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2026-02-12

No results posted yet for this study

Summary

Prospective, longitudinal, interventional, single-group, multicenter natural history study to better know the LGMD2I disease physiopathology. The duration of participation for each patient will be up to 24 months.

Conditions

  • LGMD2I

Sponsors & Collaborators

  • Genethon

    lead OTHER

Principal Investigators

  • John Vissing, PR · Professor of neurology

Eligibility

Min Age
16 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-19
Primary Completion
2023-12-14
Completion
2023-12-14

Countries

  • Denmark
  • France
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03842878 on ClinicalTrials.gov